Atlas Trials

Intestinal Adenocarcinoma of the Stomach

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Intestinal Adenocarcinoma of the Stomach

RecordFirmDate
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer (NCT02344810)Eastern Cooperative Oncology Group2015-03-06
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer (NCT01939275)City of Hope Medical Center2014-11-19
Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery (NCT01612546)City of Hope Medical Center2012-11-01
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer (NCT01231399)City of Hope Medical Center2012-02-01
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer (NCT01212822)Fox Chase Cancer Center2011-04-27
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery (NCT00991952)National Cancer Institute (NCI)2009-09-01
S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer (NCT00103324)National Cancer Institute (NCI)2004-12-01
Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00084604)National Cancer Institute (NCI)2004-04-01
Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma (NCT00084617)National Cancer Institute (NCI)2004-03-01
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496)National Cancer Institute (NCI)2001-11-01

Track Intestinal Adenocarcinoma of the Stomach automatically

Every clearance here is in the API, with alerts when new ones post.